These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32853666)

  • 1. Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry.
    Nuzzi V; Cannatà A; Manca P; Castrichini M; Barbati G; Aleksova A; Fabris E; Zecchin M; Merlo M; Boriani G; Sinagra G
    Int J Cardiol; 2021 Jan; 323():140-147. PubMed ID: 32853666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste.
    Aleksova A; Merlo M; Zecchin M; Sabbadini G; Barbati G; Vitrella G; Di Lenarda A; Sinagra G
    Clin Med Res; 2010 Dec; 8(3-4):142-9. PubMed ID: 20682760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of catheter ablation of atrial fibrillation in dilated cardiomyopathy.
    Zhao L; Xu K; Jiang W; Zhou L; Wang Y; Zhang X; Wu S; Liu X
    Int J Cardiol; 2015; 190():227-32. PubMed ID: 25920033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History.
    Gentile P; Merlo M; Cannatà A; Gobbo M; Artico J; Stolfo D; Gigli M; Ramani F; Barbati G; Pinamonti B; Sinagra G
    J Am Heart Assoc; 2019 Sep; 8(17):e010705. PubMed ID: 31431100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy.
    Dziewięcka E; Gliniak M; Winiarczyk M; Karapetyan A; Wiśniowska-Śmiałek S; Karabinowska A; Holcman K; Kostkiewicz M; Hlawaty M; Leśniak-Sobelga A; Podolec P; Rubiś P
    Kardiol Pol; 2020 Jan; 78(1):37-44. PubMed ID: 31686668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15185463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation.
    Padfield GJ; Steinberg C; Swampillai J; Qian H; Connolly SJ; Dorian P; Green MS; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
    Heart Rhythm; 2017 Jun; 14(6):801-807. PubMed ID: 28232263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G;
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15346692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Reverse Remodeling in Dilated Cardiomyopathy.
    Nuzzi V; Raafs A; Manca P; Henkens MTHM; Gregorio C; Boscutti A; Verdonschot J; Hazebroek M; Knackstedt C; Merlo M; Stolfo D; Sinagra G; Heymans SRB
    J Am Soc Echocardiogr; 2023 Feb; 36(2):154-162. PubMed ID: 36332803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.
    Aleksova A; Sabbadini G; Merlo M; Pinamonti B; Barbati G; Zecchin M; Bussani R; Silvestri F; Iorio AM; Stolfo D; Dal Ferro M; Dragos AM; Meringolo G; Pyxaras S; Lo Giudice F; Perkan A; di Lenarda A; Sinagra G
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):699-705. PubMed ID: 19474760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of atrial fibrillation in dilated cardiomyopathy.
    Takarada A; Kurogane H; Hayashi T; Fujimoto T; Yasaka Y; Fukumoto Y; Shimatani Y; Yamakawa H; Sasaki S; Matsuura A
    Jpn Heart J; 1993 Nov; 34(6):749-58. PubMed ID: 8164342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Permanent Atrial Fibrillation on Cognitive Function in Patients With Chronic Heart Failure.
    Coma M; González-Moneo MJ; Enjuanes C; Velázquez PP; Espargaró DB; Pérez BA; Tajes M; Garcia-Elias A; Farré N; Sánchez-Benavides G; Martí-Almor J; Comin-Colet J; Benito B
    Am J Cardiol; 2016 Jan; 117(2):233-9. PubMed ID: 26686573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
    Ullah W; Ling LH; Prabhu S; Lee G; Kistler P; Finlay MC; Earley MJ; Sporton S; Bashir Y; Betts TR; Rajappan K; Thomas G; Duncan E; Staniforth A; Mann I; Chow A; Lambiase P; Schilling RJ; Hunter RJ
    Europace; 2016 May; 18(5):679-86. PubMed ID: 26843584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy.
    Lalario A; Del Mestre E; Lo Casto M; Nuzzi V; Manca P; Bromage DI; Barbati G; Merlo M; Sinagra G; Cannatà A
    ESC Heart Fail; 2022 Oct; 9(5):3052-3059. PubMed ID: 35735911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and adverse events in patients with atrial fibrillation at left ventricular assist device implantation: an analysis of the European Registry for Patients with Mechanical Circulatory Support.
    Antonides CFJ; Yalcin YC; Veen KM; Muslem R; De By TMMH; Bogers AJJC; Gustafsson F; Caliskan K
    Eur J Cardiothorac Surg; 2022 May; 61(5):1164-1175. PubMed ID: 35076057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial longitudinal strain in dilated cardiomyopathy patients: is there a discrimination threshold for atrial fibrillation?
    Kurzawski J; Janion-Sadowska A; Gackowski A; Janion M; Zandecki Ł; Chrapek M; Sadowski M
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):319-325. PubMed ID: 30341669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.